Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|June 7, 2019
Repression of Acetaminophen-Induced Hepatotoxicity in HepG2 Cells by Polyphenolic Compounds from <i>Lauridia tetragona</i> (L.f.) R.H. ArcherSamuel Odeyemi, John Dewar
Oxidative Medicine and Cellular Longevity|December 31, 2020
Vhavenda Herbal Remedies as Sources of Antihypertensive Drugs: Ethnobotanical and Ethnopharmacological StudiesGundo Mudau, Samuel Odeyemi, John Dewar
World Journal of Surgical Oncology|January 19, 2006
Single dose targeted intraoperative radiotherapy (TARGIT) for breast cancer can be delivered as a second procedure under local anaestheticJayant S Vaidya, Lynn Walton, John Dewar
Breast Cancer Research : BCR|May 26, 2010
At last, a predictive and prognostic marker for radiotherapy?Philip Coates, John Dewar, Alastair M Thompson
Emerging Infectious Diseases|June 19, 2019
Nontuberculous Mycobacteria, Botswana, 2011-2014Bontle Mbeha, Madisa Mine, Modisa Sekhamo Motswaledi, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 31, 2011
Identifying suspected breast cancer: development and validation of a clinical prediction ruleColin McCowan, Peter T Donnan, John Dewar, et al.
Gastroenterology Research and Practice|September 4, 2023
Gastrointestinal Infection in South African Children under the Age of 5 years: A Mini ReviewTshepo Mafokwane, Appolinaire Djikeng, Lucky T Nesengani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST studyJohn F R Robertson, Antonio Llombart-Cussac, Janusz Rolski, et al.
Journal of Medical Virology|October 16, 2007
Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severityImène Fodha, Astrid Vabret, Leila Ghedira, et al.
Breast Cancer Research and Treatment|October 16, 2012
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' studyJohn F R Robertson, Justin P O Lindemann, Antonio Llombart-Cussac, et al.
Pageof 2